Humana marked a -4.2% change today, compared to -0.0% for the S&P 500. Is it a good value at today's price of $490.96? Only an in-depth analysis can answer that question, but here are some facts that can give you an idea:
-
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States.
-
Humana belongs to the Health Care sector, which has an average price to earnings (P/E) ratio of 24.45 and an average price to book (P/B) of 4.16
-
The company's P/B ratio is 4.0
-
Humana has a trailing 12 month Price to Earnings (P/E) ratio of 22.5 based on its trailing 12 month price to earnings (EPS) of $21.84 per share
-
Its forward P/E ratio is 15.3, based on its forward earnings per share (EPS) of $32.0
-
HUM has a Price to Earnings Growth (PEG) ratio of 1.28, which shows the company has a fair value when we factor growth into the price to earnings calculus.
-
Over the last four years, Humana has averaged free cash flows of $3,409,000,000.00, which on average grew -6.6%
-
Humana has moved 10.1% over the last year compared to -6.8% for the S&P 500 -- a difference of 17.0%
-
HUM has an average analyst rating of buy and is -18.59% away from its mean target price of $603.05 per share